B-VEC

null · Krystal Biotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for B-VEC, covering 2023-02-17 to 2024-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa [Phase 3]